Introduction: Diabetic retinopathy is the leading cause of blindness of working-age patients in the urban areas.
Introduction
Diabetes mellitus is a metabolic disease caused by an absolute or relative insufficiency of insulin. Long-term hyperglycemia is associated with changes in the microvasculature including kidney, heart, retina and other parts of the body. There is now ample evidence to show that the development of diabetic retinopathy is a multi-factorial process where genetic, metabolic and growth factors play an important role (Giusti C & Gargiulo P, 2007) . Further identification of risk factors and determinants for retinopathy is important to improve understanding of the disease mechanisms and to facilitate new treatments and preventive strategies. There are reports suggesting serum Lp(a) level as an independent risk factor for the progression of nonproliferative diabetic retinopathy (NPDR) in type 2 diabetes patients. It has, however, been recommended by some researchers that such findings be validated (Funatsu H et al 2009) .
Lipoprotein is atherogenic and thrombogenic in nature. Its oxidative form causes injury to retinal capillaries causing retinopathy. The present study was undertaken to evaluate the association between the diabetic retinopathy and serum lipoprotein level at first presentation in type II diabetic patients of an urban population of the Kathmandu valley.
Materials and methods
A cross-sectional study was carried out involving 100 subjects with type II diabetes using a purposive-sampling method. All type 2 diabetic patients screened at a diabetes education camp conducted by Astha Nepal in the urban Kathmandu valley were advised to attend the BP Koirala Lions Centre for Ophthalmic Studies (BPKLCOS) for detailed evaluation.
The patients with type 1 diabetes, hypertension, post cataract/ vitrectomy surgery, pregnancy, hazy media, retinal vaso-occlusive disease and renal diseases were excluded.
A pro forma was the tool for data collection. A dilated posterior segment examination was done with combination of 0.8% tropicamide and 5% phenyliphrine eye drops.
The Airlie House Classification of diabetic retinopathy which was subsequently modified by the Diabetic Retinopathy Study and extended by the Early Treatment Diabetic Retinopathy Study was followed.
Measurement of Hba1c level and serum lipoproteins
Glycosylated hemoglobin level and fasting serum lipoproteins of all the patients were measured. HbA1c level was recorded by gel precipitation method and was graded as follows. · Normal range : 4.2-6.2% · Good control : 6.3%-6.8% · Fair control : 6.9-7.6% · Poor control : >7.6%
Measurement of serum lipoproteins was done using photometric enzymatic methods. The following levels were considered normal.
Statistics
The SPSS version 10.0 was used for data analysis. A value of p<0.05 was considered significant. A statistician was consulted as and when necessary.
Ethical issues
An informed consent was obtained from the patients.
Results
In this study, 100 subjects (200 eyes) with type 2 diabetes mellitus (DM) were enrolled. The majority (91%) of diabetics were in the working-age groups of 31-60 years. The mean age was 48.2 ± 9.5 years ( Table  1) . Diabetes was found mostly in housewives followed by service holders ( Table 2 ). The mean duration of diabetes was 4.5 ± 3.6 years. 74% of the patients were on oral hypoglycemic drugs, 4% were on insulin and the rest on dietary control. The glycosylated hemoglobin had similar distribution in all levels. Mean glycosylated hemoglobin level was 7.0 ± 1.2 %.
Serum lipoproteins
Normal range Triglyceride 0.5-1.8mmol/l Cholesterol 3.5-8.5mmol/l HDL* 0.8-1.6mmol/l LDL* Upto 4.0mmol/l *HDL=high density lipoprotein, LDL = low density lipoprotein 
Discussion
One hundred subjects (200 eyes) with type II diabetes were included in this study. The age of them ranged from 21 to 70 years with a higher number of diabetics in the working-age groups 31-61 years (91%). Mean age was 48.2 ± 9.5 years. In the developed world, the majority of diabetics are aged 65 years and above, whereas in the developing world, the majority of diabetics are in the age group of 45-64 years. According to the Chennai Urban Rural Epidemiology Study (CURES) Eye Study I, the prevalence of diabetes in the 45 to 60 years-age-group was nearly 25% (Rema M et al 2005) . In a study done in 1980 in the west of Scotland, diabetes was responsible for 10% of blindness and was the commonest cause of blindness in the age groups of 45-54 and 55-64 years (Ghafour I et al 1983) .
In this study, the female to male ratio of diabetics was 1:1.77 with a higher prevalence of the disease in males. In another study done in a department of ophthalmology in Kathmandu the female to male ratio of diabetics was 1:1.2 (Karki M, 2004; personal communication, unpublished) . Diabetes was found mostly in housewives (28%).
In this study, the patients were screened from the urban diabetic community education camp. The duration of diabetes was significantly longer in the diabetic retinopathy group than in the no-diabetic-retinopathy group (p=0.006). 60% of diabetics of 10-12 yearduration had diabetic retinopathy, whereas 7.7% -12.9% of diabetics of 0 to 2 year-duration had diabetic retinopathy. Michael Colucciello found that more than 80% of patients who have had diabetes for 15 years also have evidence of retinopathy, the hallmark of which is retinal capillary microaneurysms (Colucciello M, 2004) . Among younger-onset patients with diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), the prevalence of diabetic retinopathy was 8% at 3 years, 25% at 5 years, 60% at 10 years, and 80% at 15 years. The prevalence of PDR was 0% at 3 years and increased to 25% at 15 years (Klein R et al 1984) .
This study showed that 21% of patients had diabetic retinopathy. Among them, the highest number of patients had mild NPDR (17%) followed by severe NPDR (3%) and moderate NPDR (1%). Similarly, Fong et al also found that up to 21% of patients with type 2 diabetes had retinopathy at the time of first diagnosis of diabetes, and most developed some degree of retinopathy over time (Donald S. et al 2003) . In the study of Chennai Urban Rural Epidemiology Eye Study (CURES) I, the overall prevalence of diabetic retinopathy in the population was 17.6% (95% CI = 15.8-19.5), which included 20.8% (95% CI: 18.7-23.1) in known diabetic subjects and 5.1% (95% CI: 3.1-8.0) in subjects with newly detected diabetes (Rema et al 2005) .
In this study, the mean glycosylated hemoglobin level was 7.0 ± 1.2 %. The mean glycosylated hemoglobin for the no-diabetic retinopathy group was 6.9±1.1% and for the diabetic retinopathy group, it was 7.7±1.5%. The HbA1c value was significantly higher in the diabetic retinopathy group than in the no-diabetic-retinopathy group (p = 0.004). In a South East Asian study, the median HbA1c level was 7.5% (Raheja et al 2001) . Salem et al studied diabetic retinopathy among Jordanians and found that mean HbA1c was 7.9±1.63 % in normal retina and 9.1%±2.18 (p =0.002) in diabetic retinopathy (Mahmoud et al 1999) .
In this study, 30.8% -38.5% of diabetics of the poorHbA1c group had diabetic retinopathy and 7.6% -11.5% of diabetics of the normal HbA1c group had diabetic retinopathy. The CURES Eye Study I found for every 2% elevation of HbA1c, the risk for diabetic retinopathy increased by a factor of 1.7. For every 2% increase in HbA1c, the risk for diabetic retinopathy was higher in those with longer duration of diabetes (Rema M et al 2005) .
In this study, all 4 serum lipoproteins (LDL, Triglyceride, HDL and total cholesterol) were measured. The mean lipoprotein values were slightly higher in the diabetic retinopathy group than in the no-diabetic retinopathy group. They were, however, not statistically significant. Serum triglyceride was high in the normal HbA1c and abnormal HbA1c groups and it was higher in the diabetic retinopathy group than in the no-diabeticretinopathy group. Serum triglyceride had a low degree of positive correlation with HbA1c value. A study conducted by the DCCT/EDIC Research Group (1993) found that ETDRS scores were significantly related to the triglyceride level in univariate analysis, whereas multivariate analysis exhibited only a borderline association in the combined cohort only and LDL cholesterol tended to increase in both genders with more Shakya K et al Nep J Oph 2009; 1(2):107-113 Diabetic retinopahty and serum lipoproteins severe retinopathy, but this was not significant in the multivariate analysis. HDL cholesterol was inversely associated with ETDRS scores in both genders with univariate analysis. More severe retinopathy was associated with a higher total triglyceride level and a lower HDL cholesterol level. Retinopathy was strongly associated with small and medium, but not large VLDL in each gender. A similar study done in Turkey by Ergun et al (2004) on lipoprotein (A) levels in type 2 diabetic patients with diabetic retinopathy revealed that the Lp(a) levels were similar in the patients with retinopathy and those without retinopathy. There was no evidence for a relationship between the serum Lp(a) levels and diabetic retinopathy in type 2 diabetic patients (Ergun UG et al 2004) .
Conclusion
There appears to be no statistically significant relationship between diabetic retinopathy and serum lipoproteins. The serum lipoprotein levels are slightly higher in the patients with diabetic retinopathy than in those without retinopathy.
All 4 serum lipoproteins have low degree of positive correlation with HbA1c value demonstrating some role of lipoproteins in pathogenesis of diabetic retinopathy.
